Blog
8 Articles
![Aqua gloved hands holding lab equipment](https://letswinpc.org/wp-content/uploads/2023/12/Customs-lab.jpg)
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
![DNA helix made of metal, plastic and stained glass](https://letswinpc.org/wp-content/uploads/2022/09/ct2020jan10.jpg)
Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers
Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.
![A latex-gloved hand doing close lab work](https://letswinpc.org/wp-content/uploads/2022/09/ct2019mar5.jpg)
Targeting Cancer-Associated Wasting With Experimental Immunotherapy
Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.
![Pancreas cross section embedded in paraffin wax, stained blue and purple, 100x magnification.](https://letswinpc.org/wp-content/uploads/2022/09/ct2017jan16.jpg)
Comparing a Standard Chemotherapy With and Without a PARP Inhibitor
A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.
![Four transparent oblong orange pills and five round white pills on an orange background](https://letswinpc.org/wp-content/uploads/2022/09/ct2016oct31.jpg)
Using a Vitamin to Make Low-Dose Chemotherapy More Effective
A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.
![lab cylinders, beakers, glass bottles upside down on a drying rack](https://letswinpc.org/wp-content/uploads/2022/10/tubes-on-rack-nci-vol-3893-150-e1477592371124.jpg)
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.